Related Experiment Video

Updated: May 7, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Distinct prognostic factors in patients with chronic heart failure and chronic kidney disease

Takamasa Sato1, Hiroyuki Yamauchi, Satoshi Suzuki

  • 1Department of Cardiology and Hematology, Fukushima Medical University.

International Heart Journal
|October 8, 2013
PubMed

Insights

Chronic kidney disease (CKD) significantly impacts heart failure prognosis. Key predictors for cardiac events differ between patients with and without CKD, necessitating tailored management strategies for heart failure patients with impaired renal function.

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Impaired renal function is a significant predictor of mortality in patients with chronic heart failure (CHF).
  • The influence of chronic kidney disease (CKD) on prognostic factors in CHF has not been thoroughly investigated.
  • Understanding these differences is crucial for effective CHF patient management.

Purpose of the Study:

  • To compare prognostic factors for cardiac events between CHF patients with and without CKD.
  • To identify distinct predictors of mortality and re-hospitalization in these two groups.
  • To inform clinical decision-making for CHF management in the presence of CKD.

Main Methods:

  • A cohort of 505 consecutive CHF patients underwent cardiopulmonary exercise testing.
  • Patients were stratified into two groups: CKD (eGFR < 60 mL/minute/1.73 m2) and non-CKD (eGFR ≥ 60 mL/minute/1.73 m2).
  • Cardiac events (death, heart failure re-hospitalization) were tracked during follow-up using Cox hazard analysis.

Main Results:

  • The cardiac event rate was substantially higher in the CKD group (34%) compared to the non-CKD group (14%).
  • In non-CKD patients, body mass index, log BNP, peak VO2, and left atrial dimension predicted events.
  • In CKD patients, peak VO2, log BNP, hemoglobin, and uric acid levels were independent prognostic factors.

Conclusions:

  • Prognostic factors for cardiac events significantly differ between CHF patients with and without CKD.
  • Current prognostic models for CHF may not be universally applicable to patients with co-existing CKD.
  • Clinical management of CHF patients with CKD requires consideration of unique prognostic indicators like hemoglobin and uric acid levels.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.